Is a complete LPCN research report available?

No complete published report is available for Lipocine Inc. (LPCN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lipocine Inc. (LPCN)

NASDAQ: LPCN · USD

$1.53

+0.07 (+4.8%)· Recorded snapshot

Market cap	12.6M
Revenue (ttm)	1.6M
Net income (ttm)	-11.9M
EPS (ttm)	-$1.82
Shares out	8.2M
Volume	185,039
Beta	0.40

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.6M
Net income (ttm): -11.9M
EPS (ttm): -$1.82
Market cap: 12.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001535955
Company name	Lipocine Inc.
Country	United States
Country code	US
CUSIP number	53630X203
Earnings date	2026-11-09
Earnings time	bmo
Employees	14
Employees change	-2
Employees growth	-12.5%
Enterprise value	$-10.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1997
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US53630X2036
Last 10-K release date	2026-03-10
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2023-05-12
Last stock split type	Reverse
Market cap	$12.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$1.53
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LPCN
U.S. state	Utah
Website	https://www.lipocine.com

Metric

Value

Amount currency

USD

CIK code

0001535955

Company name

Lipocine Inc.

Country

United States

Country code

CUSIP number

53630X203

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-2

Employees growth

-12.5%

Enterprise value

$-10.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1997

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US53630X2036

Last 10-K release date

2026-03-10

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split date

2023-05-12

Last stock split type

Reverse

Market cap

$12.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Price

$1.53

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

LPCN

U.S. state

Utah

Website

https://www.lipocine.com

Metric	Value
Earnings yield	-118.83%
FCF / EV yield	106.81%
FCF yield	-89.3%
Forward P/S	24.01x
P/B ratio	0.55x
P/S ratio	7.98x
Price / tangible book value	0.58x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-118.83%

FCF / EV yield

106.81%

FCF yield

-89.3%

Forward P/S

24.01x

P/B ratio

0.55x

P/S ratio

7.98x

Price / tangible book value

0.58x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	100%
Operating margin	-800.82%
Pretax margin	-755.11%
Profit per employee	$-846,529
Revenue per employee	$112,104
ROA	-37.04%
ROA (5Y)	-16.96%
ROCE	-57.74%
ROE	-60.94%
ROE (5Y)	-28.24%
ROIC	-39.87%
SBC / revenue	14.64%
Tax / revenue	0.01%

Metric

Value

Gross margin

100%

Operating margin

-800.82%

Pretax margin

-755.11%

Profit per employee

$-846,529

Revenue per employee

$112,104

ROA

-37.04%

ROA (5Y)

-16.96%

ROCE

-57.74%

ROE

-60.94%

ROE (5Y)

-28.24%

ROIC

-39.87%

SBC / revenue

14.64%

Tax / revenue

0.01%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-62.7%
Gross profit growth (Q)	-69.48%
Gross profit growth 3Y	205.6%
Net income growth years	0
Revenue growth	-62.7%
Revenue growth (Q)	-69.48%
Revenue growth (QoQ)	59.22%
Revenue growth 3Y	205.6%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-62.7%

Gross profit growth (Q)

-69.48%

Gross profit growth 3Y

205.6%

Net income growth years

Revenue growth

-62.7%

Revenue growth (Q)

-69.48%

Revenue growth (QoQ)

59.22%

Revenue growth 3Y

205.6%

Revenue growth years

Metric	Value
Depreciation and amortization	$58,566
EBIT	$-12.6M
EBITDA	$-12.5M
EPS	$-1.82
FCF per share	$-1.36
Financing cash flow	$16.3M
Free cash flow	$-11.2M
Free cash flow minus SBC	$-11.4M
Gross profit	$1.6M
Income taxes	$200
Investing cash flow	$-6.1M
Net cash flow	$-1.1M
Net income	$-11.9M
Operating cash flow minus SBC	$-11.4M
Operating income	$-12.6M
Revenue	$1.6M
Stock-based compensation	$229,833

Metric

Value

Depreciation and amortization

$58,566

EBIT

$-12.6M

EBITDA

$-12.5M

EPS

$-1.82

FCF per share

$-1.36

Financing cash flow

$16.3M

Free cash flow

$-11.2M

Free cash flow minus SBC

$-11.4M

Gross profit

$1.6M

Income taxes

$200

Investing cash flow

$-6.1M

Net cash flow

$-1.1M

Net income

$-11.9M

Operating cash flow minus SBC

$-11.4M

Operating income

$-12.6M

Revenue

$1.6M

Stock-based compensation

$229,833

Metric	Value
Altman Z-Score	-5.64
Book value per share	$2.64
Debt / equity	0.01
Long-term assets	$98,584
Long-term liabilities	$-0
Net cash (debt)	$23M
Net cash / market cap	183.61%
Net cash growth	30.11%
Net debt / equity	-1.06
Piotroski F-Score	1
Property, plant and equipment	$74,831
Shareholders' equity	$21.8M
Tangible book value	$21.8M
Tangible book value per share	$2.64
Total assets	$23.8M
Total cash	$23.3M
Total debt	$257,807
Total liabilities	$2.1M
WACC	6.33%

Metric

Value

Altman Z-Score

-5.64

Book value per share

$2.64

Debt / equity

0.01

Long-term assets

$98,584

Long-term liabilities

$-0

Net cash (debt)

$23M

Net cash / market cap

183.61%

Net cash growth

30.11%

Net debt / equity

-1.06

Piotroski F-Score

Property, plant and equipment

$74,831

Shareholders' equity

$21.8M

Tangible book value

$21.8M

Tangible book value per share

$2.64

Total assets

$23.8M

Total cash

$23.3M

Total debt

$257,807

Total liabilities

$2.1M

WACC

6.33%

Metric	Value
Asset turnover	0.07
Current assets	$23.7M
Current liabilities	$2.1M
Current ratio	11.48
Net working capital	$-1.3M
Quick ratio	11.39
Working capital	$21.7M
Working capital turnover	0.08

Metric

Value

Asset turnover

0.07

Current assets

$23.7M

Current liabilities

$2.1M

Current ratio

11.48

Net working capital

$-1.3M

Quick ratio

11.39

Working capital

$21.7M

Working capital turnover

0.08

Metric	Value
Buyback yield / dilution	-22.05%
Dividend yield	0%
Shareholder yield	-22.05%

Metric

Value

Buyback yield / dilution

-22.05%

Dividend yield

Shareholder yield

-22.05%

Metric	Value
10Y price change	-97.26%
10Y return CAGR	-30.21%
10Y total return	-97.26%
150-day SMA	$2.37
1D price change	4.79%
1M price change	-27.62%
1M total return	-27.62%
1W price change	-6.17%
1W total return	-6.17%
1Y price change	-46.1%
1Y return CAGR	-46.12%
1Y total return	-46.1%
20-day SMA	$1.72
200-day SMA	$4.01
3M price change	-28.97%
3M total return	-28.97%
3Y price change	-36.13%
3Y return CAGR	-13.88%
3Y total return	-36.13%
50-day SMA	$2.01
50-day SMA vs 200-day SMA	50under200
52-week high	$12.37
52-week high date	2026-01-15
52-week low	$1.40
52-week low date	2026-10-26
5Y price change	-91.32%
5Y return CAGR	-38.67%
5Y total return	-91.32%
6M price change	-35.86%
6M total return	-35.86%
All-time high	$340.00
All-time high date	2013-08-28
All-time low	$1.40
All-time low date	2026-10-19
Average true range (ATR)	$0.14
Average volume	5.7M
Beta (1Y)	-0.6
Beta (2Y)	0.29
Beta (5Y)	0.4
Change from 52-week high	-87.63%
Change from 52-week low	9.29%
Change from all-time high	-99.55%
Change from all-time low	8.57%
Change from open	2.68%
Day's gap	2.05%
Dollar volume	$283,110
High price	$1.53
Low price	$1.49
Monthly RSI	39.34
Open price	$1.49
Position in 52-week range	100%
Premarket change	0%
Premarket close	$1.46
Premarket price	$1.46
Premarket volume	5K
Previous close	$1.46
Price vs 150-day SMA	-35.76%
Price vs 20-day SMA	-11.73%
Price vs 200-day SMA	-62.07%
Price vs 50-day SMA	-24.34%
Relative volume	0.03
RSI	34.34
Sharpe ratio	0.33
Sharpe ratio (3Y)	0.37
Sharpe ratio (5Y)	-0.14
Sortino ratio	0.45
Sortino ratio (3Y)	0.56
Sortino ratio (5Y)	-0.12
Volume	185K
Weekly RSI	32.41
YTD price change	-81.07%
YTD total return	-81.07%

Metric

Value

10Y price change

-97.26%

10Y return CAGR

-30.21%

10Y total return

-97.26%

150-day SMA

$2.37

1D price change

4.79%

1M price change

-27.62%

1M total return

-27.62%

1W price change

-6.17%

1W total return

-6.17%

1Y price change

-46.1%

1Y return CAGR

-46.12%

1Y total return

-46.1%

20-day SMA

$1.72

200-day SMA

$4.01

3M price change

-28.97%

3M total return

-28.97%

3Y price change

-36.13%

3Y return CAGR

-13.88%

3Y total return

-36.13%

50-day SMA

$2.01

50-day SMA vs 200-day SMA

50under200

52-week high

$12.37

52-week high date

2026-01-15

52-week low

$1.40

52-week low date

2026-10-26

5Y price change

-91.32%

5Y return CAGR

-38.67%

5Y total return

-91.32%

6M price change

-35.86%

6M total return

-35.86%

All-time high

$340.00

All-time high date

2013-08-28

All-time low

$1.40

All-time low date

2026-10-19

Average true range (ATR)

$0.14

Average volume

5.7M

Beta (1Y)

-0.6

Beta (2Y)

0.29

Beta (5Y)

0.4

Change from 52-week high

-87.63%

Change from 52-week low

9.29%

Change from all-time high

-99.55%

Change from all-time low

8.57%

Change from open

2.68%

Day's gap

2.05%

Dollar volume

$283,110

High price

$1.53

Low price

$1.49

Monthly RSI

39.34

Open price

$1.49

Position in 52-week range

100%

Premarket change

Premarket close

$1.46

Premarket price

$1.46

Premarket volume

Previous close

$1.46

Price vs 150-day SMA

-35.76%

Price vs 20-day SMA

-11.73%

Price vs 200-day SMA

-62.07%

Price vs 50-day SMA

-24.34%

Relative volume

0.03

RSI

34.34

Sharpe ratio

0.33

Sharpe ratio (3Y)

0.37

Sharpe ratio (5Y)

-0.14

Sortino ratio

0.45

Sortino ratio (3Y)

0.56

Sortino ratio (5Y)

-0.12

Volume

185K

Weekly RSI

32.41

YTD price change

-81.07%

YTD total return

-81.07%

Metric	Value
Float	6.5M
Float percentage	79.02%
Shares change (QoQ)	20.93%
Shares change (YoY)	22.05%
Shares held by insiders	4.98%
Shares held by institutions	20.27%
Shares outstanding	8.2M
Short % of float	1.5%
Short % of shares	1.19%
Short ratio	3 days

Metric

Value

Float

6.5M

Float percentage

79.02%

Shares change (QoQ)

20.93%

Shares change (YoY)

22.05%

Shares held by insiders

4.98%

Shares held by institutions

20.27%

Shares outstanding

8.2M

Short % of float

1.5%

Short % of shares

1.19%

Short ratio

3 days

Lipocine Inc. (LPCN)

Price

Financial snapshot

Fair-value bridge

Latest news · LPCN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LPCN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LPCN

Frequently asked questions